For research use only
| Cat No. | ABC-TC0184 |
| Product Type | Human Lung Cancer Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Lung Small Cell Cancer |
| Product Code | Cor L32; CORL32 |
COR-L32 cell line is derived from the lung carcinoma, and is suitable for respiratory cancer research, drug response, and biomarker discovery.
COR-L32 is a human lung cancer cell line estalished from a marrow trephine from a poorly-differentiated squamous cell carcinoma. Morphologically, these cells display a high nucleus-to-cytoplasm ratio with dense chromatin, round to oval nuclei, and scant cytoplasm, often grow as floating aggregates of packed cells in culture. Karyotypic analysis reveals frequent chromosomal abnormalities. COR-L32 cells demonstrate rapid proliferation, anchorage-independent growth, and high metastatic potential. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Cor L32; CORL32 |
| Species | Human |
| Cat.No | ABC-TC0184 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Lung Small Cell Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
COR-L32 serves as a vital tool in oncology research and drug development. It is extensively employed in in vitro studies to investigate molecular and cellular mechanisms in SCLC, including genomic instability, neuroendocrine differentiation, and metastatic potential. This cell line is instrumental in studying cellular responses to experimental compounds and pathway-specific perturbations, such as inhibitors targeting DNA repair pathways or neuroendocrine markers.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
